Reprieve Cardiovascular
Greg Mann has extensive experience in financial leadership, currently serving as the Managing Director and Chief Financial Officer at Reprieve Cardiovascular since August 2018 and at RenalGuard Solutions, Inc. since October 2011, where Greg is also a member of the Board of Directors. Prior to these roles, Greg Mann worked at Virtusa Corporation from August 2006 to September 2011, focusing on financial reporting and analysis.
This person is not in any teams
This person is not in any offices
Reprieve Cardiovascular
Reprieve Cardiovascular is focused on improving outcomes for patients suffering from acute decompensated heart failure.